In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Glial cell line-derived neurotrophic factor (GDNF) regulates striatal dopaminergic neurons. To study whether reduced endogenous GDNF affect morphine's effects on striatal dopamine transmission, we estimated extracellular concentrations of dopamine and its metabolites by microdialysis in vivo and tissue concentrations post mortem in mice lacking one GDNF allele (GDNF+/- mice). In the wild-type mice, acute morphine (5 and 10 mg/kg s.c.) increased accumbal dopamine output dose-dependently (maximally by 30 and 80%, respectively). In the GDNF+/- mice, 5 mg/kg of morphine enhanced the accumbal dopamine output maximally by 110%, and significantly more than morphine 10 mg/kg (maximally by 60%). Also, the response of extracellular accumbal DOPAC to acute morphine was significantly altered in the GDNF+/- mice. In mice of both genotypes, the responses to morphine in the caudate putamen were similar to but much less intense than those in the nucleus accumbens. Morphine at the doses 5, 10, and 30 mg/kg dose-dependently elevated the striatal tissue concentrations of DOPAC and HVA, but the effect of 30 mg/kg was significantly smaller in the GDNF+/- mice than in their wild-type littermates. The binding of [(3)H]DAMGO to striatal membrane homogenates was similar between the genotypes. However, morphine induced antinociception in the GDNF+/- mice at a smaller dose than in the controls. The finding that reduced GDNF level alters the effects of morphine on striatal dopamine and our previous findings of elevated extracellular striatal dopamine concentrations and FosB/DeltaFosB expression in the GDNF+/- mice show the importance of GDNF in the regulation of striatal dopaminergic system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637 · cited 1×
“The activation of l-opioid receptors inhibits the inhibitory GABAergic interneurons and thus leads to enhanced release of dopamine (Johnson and North, 1992; Lacey et al., 1989).”
BackgroundRobinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
Floresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · cited 1×
“…of midbrain dopaminergic neurons, to increase their number, and to promote their recovery in animal models of Parkinson’s disease (Beck et al., 1995; Gash et al., 1996; Hoffer et al., 1994; Kearns et al., 1997; Kearns and Gash, 1995; Sauer et al., 1995; Tomac et al., 1995; Tseng et al., 1997).”
BackgroundFunctional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955
ΔFosB: A sustained molecular switch for addiction
Nestler, E. J., Barrot, M., & Self, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191352698 · Cited by 640 · cited 1×
“Both increased extracellular dopamine and DFosB have been associated with increased sensitivity to addictive drugs (Nestler et al., 2001; Robinson and Berridge, 2003).”
BackgroundPothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288 · cited 1×
“…metabolism and turnover (Ahtee et al., 1989; Attila and Ahtee, 1984), and it increases dopamine output substantially more in the nucleus accumbens than in the caudate putamen (Di Chiara and Imperato, 1986; Di Chiara and Imperato, 1988; Leone et al., 1991; Pothos et al., 1991; Rada et al., 1991).”
Background
Cited by
Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305
Self-citationMudò, G., Mäkelä, J., Liberto, V. D., Tselykh, T. V., Olivieri, M., Piepponen, P., Eriksson, O., Mälkiä, A., Bonomo, A., Kairisalo, M., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0850-z · Cited by 301
Coller, J. K., & Hutchinson, M. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.008 · Cited by 186
Lahti, L., Peltopuro, P., Piepponen, T. P., & Partanen, J. (2012) · Development · doi:10.1242/dev.071936 · Cited by 34
Metadata
- Authors
- Airavaara, M., Mijatovic, J., Vihavainen, T., Piepponen, T. P., Saarma, M., & Ahtee, L.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2006
- Volume
- 59
- Issue
- 6
- Pages
- 321-329
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W1997326851
- Cited by
- 51
- References
- 8
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. https://app.cochat.ai/papers/10.1002/syn.20245
- The paper
- Airavaara, M., Mijatovic, J., Vihavainen, T., Piepponen, T. P., Saarma, M., & Ahtee, L. (2006). In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. Synapse. https://doi.org/10.1002/syn.20245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.